United States Prostate Stent Market Key Players, Industry Overview, Supply and Consumption Demand Analysis to 2025

on

11th JANUARY 2019: The United States Prostate Stent Market witnessed a higher CAGR growth in the anticipated period. Under medical domain, urethral stents are minimally invasive therapy used to treat benign prostatic hyperplasia, detrusor sphincter and urethral stricture. Urethral stents can be used to treat prostatic urethra and are classified as permanent or temporary.
Temporary stents are further bifurcated into biodegradable and non-biodegradable. This form of therapy is particularly useful for patients who possess high anesthetic risk and are incapable of undergoing any surgical procedures such as transurethral prostatectomy or open urethroplasty for prostate enlargement and urethral stricture. Hence, urethral stents prove as an effective choice to transurethral and open procedures in diagnosing urological disorders which may affect urethra and prostate.
Commercially, urethral stents are designed to cure bladder outlet problems caused by several etiologies. Driving factors responsible for the growth of United States Prostate Stent Market includes rising rate of male population across the world with bladder and prostate problems coupled with sedentary lifestyle. Also, the rise in disposable income and availability of proper medical measures also adds to the growth of United States prostate stent industry.
Product segmentation for the United States Prostate Stent Market includes metal and plastic. Metal segment dominates the market growth in the prescribed period due to lightweight and hygiene. Segmentation for application, the United States Prostate Stent Industry includes ambulatory surgical centers, hospitality and specialty clinics. Hospitality and specialty clinics are likely to grow in the near future owing to the rising rate of patient inflow and need for medical diagnosis for male patients. Geographical segmentation for United States Prostate Stent Industry spans Southwest, The West, The Middle Atlantic, The South, The Midwest and New England. The key players in the United States Prostate Stent Market include Bard Medical, SRS Medical, CR Bard, Boston Scientific and MDS.

Comments

Post a Comment